Navigation Links
Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases

Three clinical and scientific thought-leaders in inflammatory bowel disease (IBD) research were awarded the Crohn's & Colitis Foundation's prestigious Annual National Science Awards at its 2009 Advances in Inflammatory Bowel Diseases Clinical & Research Conference ( in Hollywood, Florida on December 4th.

New York, NY (Vocus) December 17, 2009 -- Three clinical and scientific thought-leaders in inflammatory bowel disease (IBD) research were awarded the Crohn's & Colitis Foundation's prestigious Annual National Science Awards at its 2009 Advances in Inflammatory Bowel Diseases Clinical & Research Conference ( in Hollywood, Florida on December 4th. Despite the tough economic times, the conference was attended by over 1,000 physicians, nurses, researchers, and other health care professionals, a 12 percent increase in attendance over last year. Hailing from cutting-edge medical institutions around the country, the award recipients, nominated by the Foundation's National Scientific Advisory Committee (NSAC), all exemplify unparalleled dedication to the Foundation's mission of a future free from Crohn's disease and ulcerative colitis, painful and at times, debilitating digestive diseases that affect over 1.4 million Americans.

The Henry D. Janowitz, MD Lifetime Achievement Award was presented to Burton I. Korelitz, MD, past chief of the Division of Gastroenterology at Lenox Hill Hospital in New York City for his career-long dedication to the discovery and understanding of Crohn’s and colitis. For over 40 years, Dr. Korelitz has been dedicated to improving clinical care for IBD patients. His research efforts helped to establish key treatments for treating IBD such as 6-MP, azathioprine, and infliximab. In addition, his dedication and strong interest in complications of IBD as well as understanding dysplasia and cancer surveillance in colitis has made a life changing difference to countless patients and families.

The CCFA Scientific Achievement Award is presented to the outstanding clinician and basic researcher in IBD who has the courage, innovation, and vision as a leader in the scientific community. It was presented in two categories, clinical research and basic research.

Stephan R. Targan, MD, is the recipient of this year’s CCFA Scientific Achievement Award for Clinical Research. Dr. Targan serves as Director of the Inflammatory Bowel and Immunobiology Research Institute and the Division of Gastroenterology at Cedars-Sinai Medical Center. Dr. Targan is Professor of Medicine the UCLA School of Medicine and is holder of the Feintech Family Chair in Inflammatory Bowel Disease at Cedars-Sinai. Board certified in internal medicine, gastroenterology and infectious disease, Dr. Targan has been awarded investigative grants from the NIH, CCFA, as well as research contracts with numerous industry sponsors. His research has primarily focused on the genetic and immunopathologic mechanisms of inflammatory bowel disease. Dr. Targan has a long and stellar history with CCFA. Under his leadership as Chair of CCFA’s National Scientific Advisory Committee from 1989-1993, the Foundation developed its first “Challenges in IBD Research,” a consensus paper that created CCFA’s research strategic plan. This effort not only allowed CCFA to focus on its scientific endeavors, it also provided important tools to encourage Congress to increase funding to NIH for more IBD research. Dr. Targan has also served as Chair of CCFA’s Grants Council and on its Grant Review and Research Initiatives Committee.

Dr. Targan is a member of several professional organizations, including the American Gastroenterological Association, American Association of Physicians and American Society for Clinical Investigation. He has written extensively for such peer-reviewed publications as the New England Journal of Medicine, Journal of Immunology and Gastroenterology. Dr. Targan has also written numerous book chapters on the causes, effects and treatments of inflammatory bowel disease. He is the editor of the widely acclaimed textbook Inflammatory Bowel Disease: From Bench to Bedside.

The CCFA Scientific Achievement Award for Basic Research was presented to R. Balfour Sartor, MD. Dr. Sartor serves as the CCFA Chief Medical Advisor and the Midgette Distinguished Professor of Medicine in microbiology and Immunology at the University of North Carolina-Chapel Hill. Board certified in Internal Medicine and Gastroenterology, Dr. Sartor has been a faculty member at UNC for his entire academic career. His research interests focus on understanding the pathogenesis of Crohn’s disease and ulcerative colitis and translating this basic science knowledge into improved diagnosis and treatment of IBD.

About Crohn's Disease and Ulcerative Colitis
Crohn's disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn's disease may attack anywhere from the mouth to the anus, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn's disease or ulcerative colitis, with as many as 150,000 under the age of 18. Most people develop the diseases between the ages of 15 and 35.

About the Crohn's & Colitis Foundation of America
The Crohn's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 80 cents of every dollar the Foundation spends goes to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance and the American Institute of Philanthropy. For more information, contact the Foundation at 800-932-2423 or visit the CCFA web site at Join CCFA on Facebook at and follow CCFA on Twitter at

About Advances in IBD, Crohn’s & Colitis Foundation’s Clinical & Research Conference

The Advances in Inflammatory Bowel Disease, Crohn’s & Colitis Foundation’s Clinical & Research Conference has grown to become the foremost annual event for investigators and clinicians to come together, share their knowledge and experience, and learn about the latest advances and new insights for personalized care of patients with IBD.

The 2009 program included expanded sessions for nurses and pediatric specialists, as well as a new session on endoscopy advances in IBD. In addition to the ongoing discussion of the ideal positioning of biologic therapies in both Crohn’s disease and ulcerative colitis, the conference covered new biologics in development and debated whether combining biologics or using as monotherapy is preferable for Crohn’s disease. Case-based breakout sessions provided a practical look at complicated clinical issues. Each year, the outstanding faculty is comprised of expert specialists, both the familiar and the new, including some of the top thought leaders from Europe. Visit for more information.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis
2. Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research
3. Crohn's & Colitis Foundation Launches New Web Site to Commence Take Steps Walk Season: Walkers Can Take the Step that Counts Using New Interactive Features
4. Crohn's & Colitis Foundation Opens DNA Data Bank
5. Crohn's & Colitis Foundation Encourages More Virtual Event Participants: Thousands Already Helped Foundation Raise Funds for Research & Support Legislation
6. Crohn's & Colitis Foundation Issues Annual Report
7. New Source of Information on Crohn's Disease and Ulcerative Colitis Medications
8. Good Samaritan Hospital Launches Womens Center For Bladder & Pelvic Health
9. Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference
10. A World-Class HR Master's Degree Is Now Within Reach – 100% Online
11. Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users
Post Your Comments:
Related Image:
Crohn's & Colitis Foundation Presents National Science Awards to Clinical and Scientific Thought-Leaders in Inflammatory Bowel Diseases
(Date:11/30/2015)... York (PRWEB) , ... November 30, 2015 , ... In ... of his role as a top ophthalmologist on Long Island’s east end. During the ... teaching, innovations in surgery and treatment of glaucoma and cataracts, and how a visit ...
(Date:11/30/2015)... CASPER, Wyo. (PRWEB) , ... November 30, 2015 , ... ... is watching a family member, close friend, or animal pass away, death lives among ... tough moments. , Coming from a family of 11 children, author T Sky ...
(Date:11/30/2015)... ... 2015 , ... Sikka Software announced today that they are showcasing the Sikka ... make complex business decisions by providing the tools and information they need to grow ... 10 procedures customized by zip code. , The Sikka Software Ecosystem includes over ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... alliance around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in ... TIGR® Matrix is a long-term resorbable surgical mesh intended to support and reinforce ...
(Date:11/30/2015)... ... November 30, 2015 , ... SIMmersion’s ability to ... the medical schools of the future. To reach an audience of key visionaries ... ChangeMedEd conference in Chicago, organized by the American Medical Association. , AMA ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015 iCAD, ... it will feature its latest solutions for advanced ... identification of cancer at the Radiological Society of ... Chicago from November 29 to ... product advances including iReveal®, an automated breast density ...
(Date:11/30/2015)... Varian Medical Systems (NYSE: VAR ) has signed a Memorandum ... Group, the largest hospital chain in India , ... the country. The MoU was signed by Dr. K. Prabakar ... , Varian,s India managing director, in ... Varian intends to deploy its Access to Care program by leveraging ...
(Date:11/30/2015)... 2015  Precision Image Analysis Inc. (PIA), a ... announce a dramatic expansion of its capabilities as ... its ISO-9001:2008 certification for its Quality Management System, ... protocols and procedures. This expansion enables PIA to ... Core Lab services include design and optimization of ...
Breaking Medicine Technology: